BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 17325347)

  • 61. Lack of Fetal Protection against Bovine Viral Diarrhea Virus in a Vaccinated Heifer.
    Klimowicz-Bodys MD; Polak MP; Płoneczka-Janeczko K; Bagnicka E; Zbroja D; Rypuła K
    Viruses; 2022 Feb; 14(2):. PubMed ID: 35215904
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Protective effects against abortion and fetal infection following exposure to bovine viral diarrhea virus and bovine herpesvirus 1 during pregnancy in beef heifers that received two doses of a multivalent modified-live virus vaccine prior to breeding.
    Givens MD; Marley MS; Jones CA; Ensley DT; Galik PK; Zhang Y; Riddell KP; Joiner KS; Brodersen BW; Rodning SP
    J Am Vet Med Assoc; 2012 Aug; 241(4):484-95. PubMed ID: 22852575
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Evaluation of shedding of bovine herpesvirus 1, bovine viral diarrhea virus 1, and bovine viral diarrhea virus 2 after vaccination of calves with a multivalent modified-live virus vaccine.
    Kleiboeker SB; Lee SM; Jones CA; Estes DM
    J Am Vet Med Assoc; 2003 May; 222(10):1399-403. PubMed ID: 12762386
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Investigation of bovine viral diarrhea virus infections in a range beef cattle herd.
    Kelling CL; Stine LC; Rump KK; Parker RE; Kennedy JE; Stone RT; Ross GS
    J Am Vet Med Assoc; 1990 Sep; 197(5):589-93. PubMed ID: 2170313
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Vaccination of calves with contaminated batches of bovine herpes virus 1 vaccines did not result in infection with bovine virus diarrhea virus].
    Antonis AF; van Oirschot JT; van Es M; Bruschke CJ
    Tijdschr Diergeneeskd; 2001 Mar; 126(6):208-11. PubMed ID: 11285641
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Immunocompetent truncated E2 glycoprotein of bovine viral diarrhea virus (BVDV) expressed in Nicotiana tabacum plants: a candidate antigen for new generation of veterinary vaccines.
    Nelson G; Marconi P; Periolo O; La Torre J; Alvarez MA
    Vaccine; 2012 Jun; 30(30):4499-504. PubMed ID: 22554468
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Evaluation of a bovine virus diarrhea vaccine.
    Chapek ML; McClaughry LE; Wilkins LM
    Mod Vet Pract; 1978 Oct; 59(10):755-7. PubMed ID: 216898
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Intramuscular Immunization of Mice with the Live-Attenuated Herpes Simplex Virus 1 Vaccine Strain VC2 Expressing Equine Herpesvirus 1 (EHV-1) Glycoprotein D Generates Anti-EHV-1 Immune Responses in Mice.
    Liu SA; Stanfield BA; Chouljenko VN; Naidu S; Langohr I; Del Piero F; Ferracone J; Roy AA; Kousoulas KG
    J Virol; 2017 Jun; 91(12):. PubMed ID: 28404844
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Recombinant polypeptide from the gp48 region of the bovine viral diarrhea virus (BVDV) detects serum antibodies in vaccinated and infected cattle.
    Kwang J; Littledike ET; Donis RO; Dubovi EJ
    Vet Microbiol; 1992 Oct; 32(3-4):281-92. PubMed ID: 1333674
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Transient elimination of circulating bovine viral diarrhoea virus by colostral antibodies in persistently infected calves: a pitfall for BVDV-eradication programs?
    Fux R; Wolf G
    Vet Microbiol; 2012 Dec; 161(1-2):13-9. PubMed ID: 22824254
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Comparison of three commercial vaccines for preventing persistent infection with bovine viral diarrhea virus.
    Rodning SP; Marley MS; Zhang Y; Eason AB; Nunley CL; Walz PH; Riddell KP; Galik PK; Brodersen BW; Givens MD
    Theriogenology; 2010 May; 73(8):1154-63. PubMed ID: 20181385
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Safety and efficacy of an E2 glycoprotein subunit vaccine produced in mammalian cells to prevent experimental infection with bovine viral diarrhoea virus in cattle.
    Pecora A; Aguirreburualde MS; Aguirreburualde A; Leunda MR; Odeon A; Chiavenna S; Bochoeyer D; Spitteler M; Filippi JL; Dus Santos MJ; Levy SM; Wigdorovitz A
    Vet Res Commun; 2012 Sep; 36(3):157-64. PubMed ID: 22639081
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Effect of vaccination of pregnant beef heifers on the concentrations of serum IgG and specific antibodies to bovine herpesvirus 1, bovine viral diarrhea virus 1, and bovine viral diarrhea virus 2 in heifers and calves.
    Reppert EJ; Chamorro MF; Robinson L; Cernicchiaro N; Wick J; Weaber RL; Haines DM
    Can J Vet Res; 2019 Oct; 83(4):313-316. PubMed ID: 31571732
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Immunogenicity of a modified-live virus vaccine against bovine viral diarrhea virus types 1 and 2, infectious bovine rhinotracheitis virus, bovine parainfluenza-3 virus, and bovine respiratory syncytial virus when administered intranasally in young calves.
    Xue W; Ellis J; Mattick D; Smith L; Brady R; Trigo E
    Vaccine; 2010 May; 28(22):3784-92. PubMed ID: 20381643
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Measuring CMI responses using the PrimeFlow RNA assay: A new method of evaluating BVDV vaccination response in cattle.
    Falkenberg SM; Dassanayake RP; Neill JD; Walz PH; Casas E; Ridpath JF; Roth J
    Vet Immunol Immunopathol; 2020 Mar; 221():110024. PubMed ID: 32070831
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Development and validation of an ELISA for quantitation of bovine viral diarrhea virus antigen in the critical stages of vaccine production.
    Pecora A; Perez Aguirreburualde MS; Ostachuk A; Rodriguez D; Seki C; Levy MS; Bochoeyer D; Dus Santos MJ; Wigdorovitz A
    J Virol Methods; 2009 Dec; 162(1-2):170-8. PubMed ID: 19665482
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Noncytopathic bovine viral diarrhea virus can persist in testicular tissue after vaccination of peri-pubertal bulls but prevents subsequent infection.
    Givens MD; Riddell KP; Walz PH; Rhoades J; Harland R; Zhang Y; Galik PK; Brodersen BW; Cochran AM; Brock KV; Carson RL; Stringfellow DA
    Vaccine; 2007 Jan; 25(5):867-76. PubMed ID: 17005300
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Evolution of bovine viral diarrhea virus vaccines.
    Kelling CL
    Vet Clin North Am Food Anim Pract; 2004 Mar; 20(1):115-29. PubMed ID: 15062478
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Protection of pregnant cattle and their fetuses against infection with bovine viral diarrhea virus type 1 by use of a modified-live virus vaccine.
    Cortese VS; Grooms DL; Ellis J; Bolin SR; Ridpath JF; Brock KV
    Am J Vet Res; 1998 Nov; 59(11):1409-13. PubMed ID: 9829398
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Two doses of bovine viral diarrhea virus DNA vaccine delivered by electroporation induce long-term protective immune responses.
    van Drunen Littel-van den Hurk S; Lawman Z; Snider M; Wilson D; van den Hurk JV; Ellefsen B; Hannaman D
    Clin Vaccine Immunol; 2013 Feb; 20(2):166-73. PubMed ID: 23220999
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.